Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"He's gotta be getting on in age and owns a Sh-load of shares."
65 per the last 10-K and hardly what could be called a Sh-load. He beneficially (by definition) owns 4,709,777 Class A shares but he isn't actually holding ANY.
Leo Ehrlich(4) 4,709,777
(4)For Leo Ehrlich, includes (i) 2,752,310 shares of Class A common stock held by Mr. Ehrlich’s spouse, (ii) 457,467 shares of Class A common stock into which a convertible loan and accrued interest in the amount of $228,734 may be converted at $0.50 per share, (iii) vested stock options to purchase 500,000 shares of Class A common stock granted to Mr. Ehrlich under the 2016 Equity Incentive Plan, (iv) 1,000,000 shares of Class A common stock issuable upon the exercise of stock options that are currently exercisable or are exercisable within 60 days of September 28, 2023, and (v) 4,333,936 shares of Class B common stock held directly by Mr. Ehrlich. Each share of Class A common stock carries one vote and each share of Class B common stock carries ten votes on all matters before the Company’s stockholders. Class B common stock is convertible into shares of Class A common stock at the holder’s election.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm
Look what got pushed out in December without anyone noticing!
https://www.otcmarkets.com/otcapi/company/financial-report/389444/content
Something must be in the works!!!
Developments? Here's the latest news:
Plastic2Oil Announces Plan to Resume Fuel Production & Sales and Amends Veridisyn Agreement
NIAGARA FALLS, NY, Aug. 07, 2018 (GLOBE NEWSWIRE)
"The USA FDA has approved every clinical trial proposed by Ipix. "
You can't possibly know that. Admit it. If a trial had been proposed that the FDA declined to approve this CEO would have no obligation to reveal that. Doing so doesn't strike me as consistent with his historical lack of transparency.
Besides, remember the SPA agreement for ABSSSI? Didn't the FDA kick it back to CTIX with proposed changes?
"We have received from the FDA comments and considerations for incorporation into our study design."
Obviously that wouldn't have been necessary if "The USA FDA has approved every clinical trial proposed by Ipix. "
"Brilacidin has three Phase II clinical trial that did meet objective."
And zero Phase 3 trials initiated. Have any been proposed?
You made the same exact argument 7 months ago and 3 months before that.
I fully expect you to keep on making it ad infinitum in spite of the fact that there has been no definitive showing that "the science is good".
Such a standard isn't dependent on some vague criteria.
A well-designed, completed phase 3 trial meeting its primary endpoint(s) would be good evidence that the science is good. Will that ever happen? What you are calling "attacks" would certainly end if it did. They would HAVE TO end.
All that has been offered up has been excuse after excuse. And shots at the messengers who point that out.
I understand how you and some others might feel but I have no regrets. I know who is responsible for the damage to your and others Ipix investments and it isn't me.
Consider the possibility that there are a number of people who are no longer here who feel precisely the opposite of the way that you feel....people who escaped with a larger portion of their original investment than they would have today if they had held. Some people see the light sooner than others.
One of us will be proven right some day. You should continue to hold if you think that will be you. I do not. Nor do I make any apologies for having and expressing that opinion.
None of those 162 patent publications resulted in a plug nickel of drug sales being recorded on the books of IPIX.
Since 2012, the year of the first patent publication listed, major pharmaceutical companies looking for what Brilacidin can do and including it in their patent investments haven't found any reason to use it in one of their products.
162 patent search results = $0 brilacidin revenues.
"First: who is your "we"? You have no interest or investment in the Ipix or Brilacidin story."
The "We" is anyone who read the story that you quoted a piece of. And if it isn't obvious that I have some interest in IPIX and brilacidin you're choosing to be oblivious to 10 years and almost 10,000 posts worth of evidence.
"Next: what is the story half that is not told?"
It was pretty obvious to me.. Here's what they said:
"The drug recently completed a phase II clinical trial as a treatment for SARS-CoV-2, the coronavirus responsible for COVID-19."
The following, the half that wasn't told, was reported by IPIX a month before the story was published:
"Brilacidin did not show a difference compared to placebo in reducing Time to Sustained Recovery Through Day 29, the study’s primary endpoint based on clinical status."
That half. They didn't mention it and neither did you.
You're upset that I referred to it as a "story"? That's pretty sad. I use that term interchangeably with "article"....it simply refers to a written piece. Is the .00XX problem beginning to weigh on you?
From your link. As usual we're only told half of the story:
"Klein’s most recent work, conducted in collaboration with William DeGrado, a researcher at the University of California San Francisco and fellow recipient of the John Scott Award, is the discovery and development of Brilacidin, a synthetic molecule with antimicrobial properties. The drug recently completed a phase II clinical trial as a treatment for SARS-CoV-2, the coronavirus responsible for COVID-19."
https://news.temple.edu/news/2021-12-14/michael-l-klein-wins-prestigious-john-scott-award
Basilea already had a taste of what IPIX has to offer and punted it right back to Fox.
Don't you think they've already given brilacidin a look?
Is that the old "Anything's possible" theory that you are relying on?
What Beamed system are you talking about?
It's a one page website that was created in 2022. Here are the thing that changed on it since then:
"© Copyright 2022 – BeaMed"
"© Copyright 2024 – BeaMed"
Progress!
Now you're just makin' stuff up.
An approval requires both safety and efficacy.
For no indication has brilacidin been shown to provide both.
Those are the facts.
There's literally nothing to argue about.
Nonsense. If it can't be dispensed (marketed) it doesn't matter how safe it is.
As long as no one can actually take brilacidin for anything, and no one can, the issue of whether it is safe or not is moot. .
"I'm not challenging this, I'm intrigued by how something like this would work."
Don't expect an explanation any time soon.
This one is even More Classic.....
https://www.globenewswire.com/fr/news-release/2016/12/22/901271/0/en/Cellceutix-Wishes-Shareholders-Happy-Holidays-Prepares-for-2017-Focused-on-Partnerships.html
It's no longer on the website (because it talks about Prurisol) but it is worth a read.
http://www.ipharminc.com/press-release
If brilacidin could have helped anyone, something that has never been adequately established, only one person is to blame.
Been a long time since we saw one of these:
http://www.ipharminc.com/new-blog/2018/11/22/innovation-pharmaceuticals-wishes-shareholders-a-happy-thanksgiving
I asked "What is the meaning of this?!?" and you answered that "The USA FDA approval is for the laser surgery instrument."
You didn't identify "the laser surgery instrument" (neither has the Company) and I asked what the the predicate invention was and didn't get an answer.
It reminded me somehow of this exchange from earlier this year when you seemed to think that the CEO's abandonment of 11M of his Class B shares, which had been earlier touted as protection against an unwanted takeover, was a good thing. I asked about it and heard nothing back.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=170899446
Now, as the tax year comes to an end, I'm wondering if you think the CPA will be abandoning his last 4.3M Class B shares....the only ownership in IPIX that he has retained?
Finally, can you think of a reason why the CEO of this Company has chosen to hold zero Class A shares while you have continued to accumulate them?
("I am happy I bought an other big bag full of Ipix action below USD$.015"..... https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171645380 )
"I'll be back in at 001"
What did you sell out at? I missed that post.
The largest "Sell" so far today was for 175,000 shares valued at $892.50. Was that your big bet or did you roll the dice for something less? Dollar cost averaging is a viable strategy.....as long as the shares eventually go up.
By the way I've quoted Ihub on this issue at least 3 times:
"Trade definitions are based on the mid-price and are indicative only"
Hopefully you'll understand what that means and why it's done someday soon....hopefully before you reassert your conclusion that "no one is really selling even if they come up as sells".
As you know the following was linked via a line described as "Summary" on the 510(k) Premarket Notification for the Manta equipment:
https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222701.pdf
I expect that you noticed that the latest 510(k) Premarket Notification doesn't have a Summary line on it. If it did we would know what BeaMed material was covered and the predicate(s) for it.
https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k
"There is no 510(k) form; however, 21 CFR 807 Subpart E describes requirements for a 510(k) submission."
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=807&showFR=1&subpartNode=21:8.0.1.1.5.5
The Company would have had to supply the "missing" information to the FDA. I have no idea why that submission wasn't included or for that matter whether it is typically included int the public filing of the Notification, but obviously it WAS included in the Manta Notification.
When will you be answering this?
"What's the meaning of the info at the link?"
https://investorshub.advfn.com/boards/manage_msg.asp?message_id=173455181
Just ask the person who gave you the link....but I'll bet they don't know either.
I did. I don't.
"Blast off count down beginning tomorrow."
"Tomorrow" was yesterday. How'd it go?
Oh that's right:
0.0043
0.0003 (7.50%)
Volume: 400,940
Total Trades: 24
Dollar Volume: $1,716
That's some blast off. Frothy but down?
Glad somebody is keeping track.
Good call!
Didn't find it. Just posted it. Can't explain what it's for.
Smart boss. The epitome of beating a dead horse.
If he/she is hiring I work pretty cheap and there's less cleaning up to do here every day so I have some spare time.
Not a question of honesty. I could only stand your relentless pressure for so long so I finally I gave in. My boss is gonna be royally pissed. Besides, I knew you would believe anything I told you....after all, you're an IPIX shareholder and hence supremely gullible.
Just ask this guy:
"Blast off count down beginning tomorrow. Any shares you can at these heavily manipulated prices will be Gold in your bank."
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0043
0.0003 (7.50%)
Volume: 400,940
Total Trades: 24
Dollar Volume: $1,716
Frothy.
I don't really. My boss feeds me the questions and I just post 'em. Just like you post your discoveries when a certain party provides them to you, like this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173454745
No one in their right mind would believe that you found that on your own.
That's kind of why I asked. Any idea how one can find the version of this applicable to the current 510(K)?
https://www.accessdata.fda.gov/cdrh_docs/pdf22/K222701.pdf
"The USA FDA approval is for the laser surgery instrument."
Is it? That's all I wanted to know.
Do you know what the specific predicate device was?
What's the meaning of the info at the link?
Obviously we aren't getting it. The entire market is wrong about the value of IPIX....only une petite handful of people have it figured out. The market'll get it right eventually....just wait and see.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.004
-0.001 (-20.00%)
Volume: 611,401
Total Trades: 30
Daily Volume: $2,884
Only a matter of time.
His last voluntary public statement appears to have been made in August. I guess he's busy.
Seems he's been busy for a while. From the current OTCMarkets:
BUSINESS DESCRIPTION
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
ps. I didn't make this up:
"candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future"
Maybe a gag order isn't such a bad idea.
Last I heard the 36 healthy patients had been recruited and that's all I heard.
2nd request:
Please consider adding this as a Sticky: https://ctri.nic.in/Clinicaltrials/showallp.php?mid1=67454&EncHid=&userName=Karveer Meditech
"I think it safe to say that a great majority of ADVFN Plc revenue is derived from advertising and franchise fees."
Maybe so. The fact remains that I make a financial contribution and you freeload...it surprises me not that you can't see how those things are connected.
"I also think it safe to say the primary reason you subscribe is for access to the search feature"
Absolutely (although there are other helpful features). Not only for the purpose of catching people trying to revise history but also to have ready access to the Company's past as it has been chronicled here. BTW, it's very difficult to search your posts and find anything relevant to the operations of the Company. A free membership doesn't preclude such things, you know.
"Oh well, I don't mind."
You don't mind what?
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0052
0.0003 (6.12%)
Volume: 394,545
Total Trades: 40
Daily Volume: $1,940
"He has paid to post anything he likes on this board"
Bullshit. While you and he are free to post on this board (not exactly everything you like, btw....there are a few rules), neither of you has paid for the privilege. Others (ahem) are funding your posting privileges.
I don't mind, but it would be nice to see some meaningful content once in a while to the extent that you are capable.
I'll get you started:
I like IPIX because.....
25 convincing words or less will do. Maybe talk about the drug development progress or the financial status or even something about what you feel "about the future of IPIX".....I don't mind a little RELEVANT science fiction.
From where I sit:
There are no active clinical trials. The few development partners have bailed.
There's very little cash in the till, no accessible registration statement in place so the paucity of available shares can't be sold, and no prospects for a lender. There has not even been the kind of hint that there's a clamoring to buy IPIX assets as we used to see buried in a filing.
The future's not ours to see, que sera, sera (just ask Snowy).
Go!
Thanks. But why do you never write about IPIX?
Is it really "because I don't believe I know any more about the future of IPIX than anyone frequenting the IPIX board"?
"I'm going to pretend for a moment that you asked me about why I maintain the stance that I do."
Who would ask you that? If you actually have a stance it is very well disguised.
"Based on the above facts I can't imagine my having any sinister value worth compensating much less putting me on some sort of regular payroll."
What facts? Me neither.
IPIX
Innovation Pharmaceuticals Inc (PK)
0.0049
-0.0007 (-12.50%)
Volume: 253,099
Total Trades: 17
Daily Volume: $ 1,351
Avg trade execution....$79.47
The thing's a gold mine.